NAFLD is closely related to metabolic disorders, such as insulin resistance and obesity [13], and is also related to variability in some important NAFLD genes (i.e., PNPLA3 and TM6SF2) [14]. This evidence concerns the gene TM6SF2 and metabolic dysfunction-associated steatotic liver disease.